Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 Miami, FL – February 26, 2025…
Read More
Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 Miami, FL – February 26, 2025…
Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 Miami, FL – February 26, 2025…
media@printbio.com
investors@printbio.com
Corporate Office: 9511 Collins Avenue #1403, Surfside FL. 33154
R&D Facility: 51-36 35th Street, Long Island City NY 11101
© 2025 Investor Relations. All rights reserved. Privacy Policy • Terms of Use